Sarah Ketterer - Causeway Capital Management Holdings – 2026 Q1
Explore the latest portfolio disclosure for Sarah Ketterer - Causeway Capital Management, with insights into sector exposure, position sizes, and overall investment structure for 2026 Q1.
The latest 2026 Q1 filing shows that Sarah Ketterer - Causeway Capital Management maintains its largest exposure in Unclassified Sector, which represents approximately 35.95% of the portfolio. This sector forms the core of Sarah Ketterer - Causeway Capital Management's investment stance during this reporting period.
Additional major allocations include Healthcare (about 22.58%) and Consumer Cyclical (approximately 22.00%) , reflecting how Sarah Ketterer - Causeway Capital Management diversifies beyond its primary sector focus.
These sector weightings provide a clear view into Sarah Ketterer - Causeway Capital Management's positioning and conviction areas for the 2026 Q1 quarter.
Breakdown by Sector
| Symbol | Shares | Reported Price(USD) | Action | Change % | Portfolio Weight | Position Value | Filing Period |
|---|---|---|---|---|---|---|---|
| CLS | 24,809 | $281.19 | Reduced | -66.16% | 0.09% | $6.98M | 2026 Q1 |
| TME | 612,900 | $9.28 | Reduced | -63.72% | 0.07% | $5.69M | 2026 Q1 |
| QFIN | 330,288 | $12.91 | Reduced | -74.72% | 0.05% | $4.26M | 2026 Q1 |
| EFA | 37,761 | $97.14 | Reduced | -54.51% | 0.05% | $3.67M | 2026 Q1 |
| EWT | 37,151 | $70.93 | Reduced | -80.48% | 0.03% | $2.64M | 2026 Q1 |
| MMYT | 64,544 | $37.29 | Reduced | -5.30% | 0.03% | $2.41M | 2026 Q1 |
| ACWI | 15,421 | $138.38 | Increased | 41.02% | 0.03% | $2.13M | 2026 Q1 |
| KSA | 52,898 | $39.76 | Buy | 100.00% | 0.03% | $2.1M | 2026 Q1 |
| EFXT | 52,946 | $20.85 | Reduced | -27.90% | 0.01% | $1.1M | 2026 Q1 |
| ITRN | 20,439 | $49.02 | No Change | No Change | 0.01% | $1M | 2026 Q1 |
| INMD | 71,829 | $13.69 | No Change | No Change | 0.01% | $983.34K | 2026 Q1 |
| WIT | 443,164 | $2.12 | Reduced | -6.37% | 0.01% | $939.51K | 2026 Q1 |
| NVDA | 3,589 | $174.42 | Reduced | -4.50% | 0.01% | $625.99K | 2026 Q1 |
| GSK | 11,110 | $55.18 | Reduced | -67.22% | 0.01% | $613.05K | 2026 Q1 |
| SCZ | 7,100 | $78.45 | Buy | 100.00% | 0.01% | $557K | 2026 Q1 |
| VEU | 6,191 | $75.11 | Reduced | -57.26% | 0.01% | $465.01K | 2026 Q1 |
| BTG | 94,491 | $4.53 | No Change | No Change | 0.01% | $428.04K | 2026 Q1 |
| HAFN | 54,367 | $7.65 | Buy | 100.00% | 0.01% | $415.91K | 2026 Q1 |
| VWO | 7,469 | $54.09 | Reduced | -87.67% | 0.00% | $404K | 2026 Q1 |
| JBS | 20,994 | $17.96 | No Change | No Change | 0.00% | $377.05K | 2026 Q1 |
| PDS | 3,291 | $98.15 | No Change | No Change | 0.00% | $323.01K | 2026 Q1 |
| B | 7,736 | $40.85 | Reduced | -99.87% | 0.00% | $316.02K | 2026 Q1 |
| RNR | 994 | $296.78 | Increased | 39.61% | 0.00% | $295K | 2026 Q1 |
| MSFT | 772 | $370.47 | Reduced | -20.00% | 0.00% | $286K | 2026 Q1 |
| BWLP | 15,291 | $17.59 | Buy | 100.00% | 0.00% | $268.97K | 2026 Q1 |